Annual Revenue
$35.00 M
-$335.00 M-90.54%
December 31, 2024
Summary
- As of February 23, 2025, CRSP annual revenue is $35.00 million, with the most recent change of -$335.00 million (-90.54%) on December 31, 2024.
- During the last 3 years, CRSP annual revenue has fallen by -$878.08 million (-96.17%).
- CRSP annual revenue is now -96.17% below its all-time high of $913.08 million, reached on December 31, 2021.
Performance
CRSP Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$35.00 M
NaN%
December 31, 2024
Summary
- As of February 23, 2025, CRSP quarterly revenue is $35.00 million
- Over the past year, CRSP quarterly revenue has stayed the same.
- CRSP quarterly revenue is now -96.11% below its all-time high of $900.20 million, reached on June 30, 2021.
Performance
CRSP Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$35.00 M
NaN%
December 31, 2024
Summary
- As of February 23, 2025, CRSP TTM revenue is $35.00 million
- Over the past year, CRSP TTM revenue has stayed the same.
- CRSP TTM revenue is now -96.17% below its all-time high of $913.08 million, reached on December 31, 2021.
Performance
CRSP TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
CRSP Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -90.5% | 0.0% | 0.0% |
| 3 y3 years | -96.2% | 0.0% | 0.0% |
| 5 y5 years | -87.9% | 0.0% | 0.0% |
CRSP Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -96.2% | +7927.5% | -82.5% | >+9999.0% | -96.2% | +7927.5% |
| 5 y | 5-year | -96.2% | +7927.5% | -96.1% | >+9999.0% | -96.2% | +7927.5% |
| alltime | all time | -96.2% | >+9999.0% | -96.1% | >+9999.0% | -96.2% | >+9999.0% |
CRISPR Therapeutics AG Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $35.00 M(-90.5%) | $35.00 M(-82.5%) | $35.00 M(-90.5%) |
| Dec 2023 | $370.00 M(>+9900.0%) | $200.00 M(+185.7%) | $370.00 M(+117.5%) |
| Jun 2023 | - | $70.00 M(-30.0%) | $170.10 M(+69.7%) |
| Mar 2023 | - | $100.00 M(>+9900.0%) | $100.26 M(>+9900.0%) |
| Dec 2022 | $436.00 K(-100.0%) | $6000.00(-93.6%) | $436.00 K(-96.6%) |
| Sep 2022 | - | $94.00 K(-40.5%) | $12.78 M(-1.8%) |
| Jun 2022 | - | $158.00 K(-11.2%) | $13.01 M(-98.6%) |
| Mar 2022 | - | $178.00 K(-98.6%) | $913.06 M(-0.0%) |
| Dec 2021 | $913.08 M(>+9900.0%) | $12.35 M(+3653.2%) | $913.08 M(+1.3%) |
| Sep 2021 | - | $329.00 K(-100.0%) | $900.93 M(+0.0%) |
| Jun 2021 | - | $900.20 M(>+9900.0%) | $900.75 M(>+9900.0%) |
| Mar 2021 | - | $202.00 K(+4.1%) | $588.00 K(+8.3%) |
| Dec 2020 | $543.00 K(-99.8%) | $194.00 K(+31.1%) | $543.00 K(-99.3%) |
| Sep 2020 | - | $148.00 K(+236.4%) | $77.36 M(-73.2%) |
| Jun 2020 | - | $44.00 K(-72.0%) | $289.14 M(-0.1%) |
| Mar 2020 | - | $157.00 K(-99.8%) | $289.42 M(-0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $289.59 M(+9169.8%) | $77.02 M(-63.7%) | $289.59 M(+36.2%) |
| Sep 2019 | - | $211.93 M(>+9900.0%) | $212.69 M(>+9900.0%) |
| Jun 2019 | - | $318.00 K(-3.0%) | $1.32 M(-36.8%) |
| Mar 2019 | - | $328.00 K(+185.2%) | $2.09 M(-33.0%) |
| Dec 2018 | $3.12 M(-92.4%) | $115.00 K(-79.6%) | $3.12 M(-91.2%) |
| Sep 2018 | - | $563.00 K(-48.3%) | $35.33 M(-4.9%) |
| Jun 2018 | - | $1.09 M(-19.9%) | $37.16 M(-6.3%) |
| Mar 2018 | - | $1.36 M(-95.8%) | $39.65 M(-3.3%) |
| Dec 2017 | $41.00 M(+693.9%) | $32.33 M(+1254.2%) | $41.00 M(+272.2%) |
| Sep 2017 | - | $2.39 M(-33.4%) | $11.02 M(+8.2%) |
| Jun 2017 | - | $3.58 M(+32.5%) | $10.18 M(+37.7%) |
| Mar 2017 | - | $2.70 M(+15.3%) | $7.39 M(+43.1%) |
| Dec 2016 | $5.16 M(+1990.7%) | $2.34 M(+51.3%) | $5.16 M(+68.4%) |
| Sep 2016 | - | $1.55 M(+94.8%) | $3.07 M(+102.0%) |
| Jun 2016 | - | $795.00 K(+67.0%) | $1.52 M(+110.0%) |
| Mar 2016 | - | $476.00 K(+92.7%) | $723.00 K(+192.7%) |
| Dec 2015 | $247.00 K | $247.00 K | $247.00 K |
FAQ
- What is CRISPR Therapeutics AG annual revenue?
- What is the all time high annual revenue for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual revenue year-on-year change?
- What is CRISPR Therapeutics AG quarterly revenue?
- What is the all time high quarterly revenue for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly revenue year-on-year change?
- What is CRISPR Therapeutics AG TTM revenue?
- What is the all time high TTM revenue for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG TTM revenue year-on-year change?
What is CRISPR Therapeutics AG annual revenue?
The current annual revenue of CRSP is $35.00 M
What is the all time high annual revenue for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual revenue is $913.08 M
What is CRISPR Therapeutics AG annual revenue year-on-year change?
Over the past year, CRSP annual revenue has changed by -$335.00 M (-90.54%)
What is CRISPR Therapeutics AG quarterly revenue?
The current quarterly revenue of CRSP is $35.00 M
What is the all time high quarterly revenue for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly revenue is $900.20 M
What is CRISPR Therapeutics AG quarterly revenue year-on-year change?
Over the past year, CRSP quarterly revenue has changed by $0.00 (0.00%)
What is CRISPR Therapeutics AG TTM revenue?
The current TTM revenue of CRSP is $35.00 M
What is the all time high TTM revenue for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high TTM revenue is $913.08 M
What is CRISPR Therapeutics AG TTM revenue year-on-year change?
Over the past year, CRSP TTM revenue has changed by $0.00 (0.00%)